Datta-Mannan A[au] - Search Results

Year	Number of Results
2004	2
2006	2
2007	2
2008	1
2012	3
2013	1
2014	4
2015	4
2016	2
2018	2
2019	4
2020	3
2021	1

1

Monoclonal Antibodies: Past, Present and Future.

Posner J, Barrington P, Brier T, Datta-Mannan A. Posner J, et al. Among authors: datta mannan a. Handb Exp Pharmacol. 2019;260:81-141. doi: 10.1007/164_2019_323. Handb Exp Pharmacol. 2019. PMID: 31820172 Review.

2

Antibody Conjugates-Recent Advances and Future Innovations.

Leung D, Wurst JM, Liu T, Martinez RM, Datta-Mannan A, Feng Y. Leung D, et al. Among authors: datta mannan a. Antibodies (Basel). 2020 Jan 8;9(1):2. doi: 10.3390/antib9010002. Antibodies (Basel). 2020. PMID: 31936270 Free PMC article. Review.

3

Mechanisms Influencing the Pharmacokinetics and Disposition of Monoclonal Antibodies and Peptides.

Datta-Mannan A. Datta-Mannan A. Drug Metab Dispos. 2019 Oct;47(10):1100-1110. doi: 10.1124/dmd.119.086488. Epub 2019 May 1. Drug Metab Dispos. 2019. PMID: 31043438 Review.

4

Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies.

Datta-Mannan A, Estwick S, Zhou C, Choi H, Douglass NE, Witcher DR, Lu J, Beidler C, Millican R. Datta-Mannan A, et al. MAbs. 2020 Jan 1;12(1):1770028. doi: 10.1080/19420862.2020.1770028. MAbs. 2020. PMID: 32486889 Free PMC article.

5

Influence of FcRn binding properties on the gastrointestinal absorption and exposure profile of Fc molecules.

Lawrence SA, Blankenship R, Brown R, Estwick S, Ellis B, Thangaraju A, Datta-Mannan A. Lawrence SA, et al. Among authors: datta mannan a. Bioorg Med Chem. 2021 Feb 15;32:115942. doi: 10.1016/j.bmc.2020.115942. Epub 2020 Dec 21. Bioorg Med Chem. 2021. PMID: 33461147

6

Modulation of the Biophysical Properties of Bifunctional Antibodies as a Strategy for Mitigating Poor Pharmacokinetics.

Datta-Mannan A, Brown RM, Fitchett J, Heng AR, Balasubramaniam D, Pereira J, Croy JE. Datta-Mannan A, et al. Biochemistry. 2019 Jul 16;58(28):3116-3132. doi: 10.1021/acs.biochem.9b00074. Epub 2019 Jul 8. Biochemistry. 2019. PMID: 31241304

7

Follistatin: a novel therapeutic for the improvement of muscle regeneration.

Yaden BC, Croy JE, Wang Y, Wilson JM, Datta-Mannan A, Shetler P, Milner A, Bryant HU, Andrews J, Dai G, Krishnan V. Yaden BC, et al. Among authors: datta mannan a. J Pharmacol Exp Ther. 2014 May;349(2):355-71. doi: 10.1124/jpet.113.211169. Epub 2014 Mar 13. J Pharmacol Exp Ther. 2014. PMID: 24627466

8

Application of FcRn binding assays to guide mAb development.

Datta-Mannan A, Wroblewski VJ. Datta-Mannan A, et al. Drug Metab Dispos. 2014 Nov;42(11):1867-72. doi: 10.1124/dmd.114.059089. Epub 2014 Jul 14. Drug Metab Dispos. 2014. PMID: 25024401 Review.

9

The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.

Datta-Mannan A, Choi H, Stokell D, Tang J, Murphy A, Wrobleski A, Feng Y. Datta-Mannan A, et al. AAPS J. 2018 Sep 25;20(6):103. doi: 10.1208/s12248-018-0263-0. AAPS J. 2018. PMID: 30255287

10

Inhibition of activin A ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice.

Yaden BC, Wang YX, Wilson JM, Culver AE, Milner A, Datta-Mannan A, Shetler P, Croy JE, Dai G, Krishnan V. Yaden BC, et al. Among authors: datta mannan a. Am J Pathol. 2014 Apr;184(4):1152-66. doi: 10.1016/j.ajpath.2013.12.029. Am J Pathol. 2014. PMID: 24655377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results